Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Amgen has announced plans to invest $550 million to build a new multi-product biologic drug-substance manufacturing facility in Holly Springs, North Carolina. The new plant will support traditional stainless-steel-fed batch manufacturing and...

GlaxoSmithKline (GSK) has appointed Brian McNamara, the CEO of GSK Consumer Healthcare, a joint venture between GSK and Pfizer, as CEO Designate of a new, to-be-listed Consumer Healthcare company that will result from the proposed demerger of the...

Amgen has agreed to acquire Teneobio, a Newark, California-based clinical-stage bio/pharmaceutical company developing human heavy-chain antibodies, in a deal worth up to $2.5 billion ($900 million upfront and up to an additional $1.6 billion in...

Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, plans to invest approximately $1.8 billion over six years to expand its research, preclinical manufacturing, and support facilities at its headquarters in Tarrytown,...

AstraZeneca has completed its $39-billion acquisition of Alexion Pharmaceuticals, a Boston-based bio/pharmaceutical company focused on rare diseases. The companies had announced the deal in December 2020. The acquisition marks AstraZeneca’s entry...